Fuelling Digital Pathology Advances Using Artificial Intelligence
Leveraging the Interplay between Leading Edge Computing and Digital Imaging Solutions toward Precision Medicine
22-Apr-2020
Global
Technology Research
D94E-01-00-00-00
HC03284-GL-TR_24334
The astonishing progress of combinatorial chemistry, the development of high throughput screening techniques, parallel computing, and quantum mechanics modeling approaches, among many other cutting-edge innovations, has derived in a Big Data explosion.
In parallel, the advent of structural biology, the omics revolution, and the extraordinary progress of computational science and communication technologies, have enables to face the most concerning challenges associated with the Big Data revolution: complexity, high scaling, speedy growth, source diversity, structure level, and uncertainty.
Artificial intelligence (AI)-driven platforms hold the promise to smartly embody and reshape the most remarkable advances simultaneously reaching their apogee in the present era to energize the medical diagnostics industry with novel, smart approaches to digital pathology.
The real potential of artificial intelligence (AI) to revolutionize digital pathology is just beginning to be noticed.
AI-driven technology capabilities range from the acceleration of the computational analysis of atomic and molecular properties in the tissue, the bases of de novo diagnostics strategies, and drug response comparison, to the optimization of companion diagnostics methodologies and post-treatment surveillance policies.
1.1 Research Focus
1.2 Research Scope
1.3 Analysis Framework
1.4 Research Methodology
2.1 Role of Artificial Intelligence in Digital Pathology
2.2 AI-based Tools Driving Medical Diagnostics
2.3 Key Aspects to Consider for Further Evolution
2.4 Key Definitions and Landscape Notes
2.5 Current Workflow and Future Possibilities
2.6 Breakdown of the Main Technologies in Digital Pathology
3.1 Major Concepts in AI-driven Digital Pathology
3.2 Principal Aspects of AI-based Analysis Algorithms
3.3 Efficient WSI Integration for Improved Workflow
3.4 Strategic Technology Integration
3.5 Phased Workflow Implementation
3.6 AI-driven Digital Pathology Main Stakeholders
4.1 IP Global Analysis by Assignee
4.2 IP Analysis by Academic Institution and Region
4.3 Year-wise Global IP Analysis
4.4 Repercussions in Businesses and Processes
4.5 Strategic Imperatives for Future Work
4.6 AI-driven Digital Pathology Cluster of Services
4.7 AI-driven Digital Pathology Vendor Ecosystem
4.8 Business Model Stratification and Assessment
4.9 Big Data as Enabler of AI-driven Digital Pathology
4.10 Datasets Generators for Regulatory Validation
4.11 Mainstream Clinical Applications in Focus
5.1 Healthcare Ecosystem in 2025
5.2 AI-driven Digital Pathology Solutions Mapping
5.3 Technologies Coming in the Next Five Years
5.4 Roadmap for AI-driven Digital Pathology
6.1 Global Digital Pathology Market Forecast
6.2 Global Digital Pathology Market Forecast by Product
6.3 Global Digital Pathology Market Forecast by Application
6.4 Global Digital Pathology Market Forecast by End User
6.5 Global Digital Pathology Market Forecast by Region
7.1 Private Equity Opportunities in Digital Pathology
7.2 Sustained Commitment to AI/DP Supporting M&As
7.3 Aerospace & Defense Firms Investing in AI/DP
7.4 Aerospace & Defense Principal M&A Transactions
7.5 Government IT Systems Small Business Innovation
8.1 Aiforia
8.2 ContextVision
8.3 Deciphex
8.4 IndicaLabs
8.5 Barco
8.6 Inspirata
8.7 Leica Biosystems
8.8 Flagship Biosciences
8.9 Regional Focus – Latin America
9.1 Industry Convergence in Healthcare Transformation
9.2 Comparison of Major Deals – Up to $34 Billion
9.3 Comparison of Major Deals – Up to $2 Billion
9.4 Comparison of Major Deals – Up to $750 Million
9.5 Comparison of Major Deals – Up to $290 Million
9.6 Comparison of Major Deals – Up to $195 Million
9.7 Comparison of Major Deals – Up to $156 Million
9.8 Comparison of Major Deals – Up to $105 Million
9.9 Comparison of Major Deals – Up to $75 Million
9.10 Comparison of Major Deals – Up to $60 Million
9.11 Comparison of Major Deals – Up to $50 Million
9.12 Comparison of Major Deals – Up to $38 Million
9.13 Comparison of Major Deals – Up to $30 Million
9.14 Comparison of Major Deals – Up to $22 Million
9.15 Comparison of Major Deals – Up to $12 Million
9.16 Comparison of Major Deals – Up to $10 Million
9.17 Comparison of Major Deals – Up to $5 Million
9.18 Comparison of Major Deals – Up to $3 Million
9.19 Comparison of Major Deals – Up to $1 Million
9.20 Comparison of Major Deals – Other Agreements
9.21 US Vendors in AI-drive Healthcare Systems
10.1 Key Industry Participants
10.2 Key Industry Integrators
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.